AmerisourceBergen is a global healthcare services company focused on the sourcing, distribution and related services for pharmaceuticals and healthcare products. Formed through the merger of AmeriSource Health Corporation and Bergen Brunswig in 2001, the company operates as a major intermediary between pharmaceutical manufacturers and the broad healthcare continuum, including hospitals, health systems, independent and chain pharmacies, physician practices, and specialty care providers. Publicly traded, AmerisourceBergen is widely recognized for its large-scale pharmaceutical logistics and supply chain operations as well as for a suite of services that support manufacturers’ commercialization, patient access, and the operational needs of healthcare providers. Company overview AmerisourceBergen’s core role is to procure, store, and distribute a wide range of pharmaceutical products—branded and generic prescription medicines, specialty pharmaceuticals, over-the-counter products, and certain medical supplies—across an extensive distribution network. The company supplies products to acute-care hospitals, ambulatory care sites, community pharmacies, and specialty care centers, enabling providers to maintain inventory and meet patient needs. Beyond physical distribution, AmerisourceBergen offers services designed to reduce complexity for manufacturers and providers, improve access to specialty therapies, and enhance supply chain resiliency. Core business activities AmerisourceBergen’s primary business activities include wholesale pharmaceutical distribution, specialty distribution and services, and manufacturer-focused commercialization and consulting services. The distribution business manages large-scale warehousing, cold-chain logistics, order fulfillment, and transportation to deliver pharmaceuticals reliably and compliantly. Specialty distribution and services address high-cost, complex therapies—particularly in oncology, rare diseases, and biologics—providing clinical support programs, hub services that assist patients with benefits and adherence, and specialty pharmacy capabilities for dispensing and clinical management of specialty drugs. For pharmaceutical and biotech manufacturers, AmerisourceBergen delivers commercialization support such as market access strategy, patient services, channel management, medical communications, regulatory logistics, and product launch services. Main products and services - Pharmaceutical wholesale distribution: centralized procurement and distribution of branded and generic prescription medicines and over-the-counter products to hospitals, health systems, pharmacies, and clinics. - Specialty pharmacy and specialty distribution: management and distribution of high-cost, complex medicines with associated clinical support, adherence programs, and patient education. - Manufacturer services and commercialization: outsourced services for pharmaceutical and biotech manufacturers, including sales channel logistics, market access support, patient assistance programs, product launch and reimbursement strategy, and clinical trial supply management. - Supply chain and distribution solutions: warehousing, temperature-controlled storage, serialization and traceability services, returns management, regulatory-compliant packaging, and last-mile logistics. - Data and analytics: service offerings to support inventory optimization, demand forecasting, market insights, and performance analytics to help providers and manufacturers make informed decisions about supply and distribution. - Clinical and patient support programs: services that facilitate patient enrollment in assistance programs, benefit verification, prior authorization support, and care coordination to improve therapy initiation and adherence. Customers and markets AmerisourceBergen serves a wide set of customers across the healthcare ecosystem. Its direct customers include hospitals and health systems, group purchasing organizations, chain and independent pharmacies, physician practices and clinics, specialty care providers, and pharmaceutical and biotech manufacturers seeking outsourced commercialization and logistics support. The company operates and provides services in multiple countries and maintains a network of distribution centers and logistics partners to support both domestic and international product flows. Business positioning and capabilities AmerisourceBergen positions itself as a strategic supply chain partner for both healthcare providers and product manufacturers. Its capabilities emphasize scale, regulatory and compliance infrastructure, and integrated services that combine distribution with clinical, financial, and technology-enabled solutions. By coupling logistics with manufacturer services—such as patient hub programs, reimbursement support, and commercialization consulting—the company aims to reduce barriers to therapy access, manage complex specialty product flows, and support product launches. The company also invests in systems and processes for cold-chain management, serialization, recall handling, and other quality-driven distribution practices required for modern pharmaceutical products. Regulatory and compliance focus Because pharmaceutical distribution and specialty services are heavily regulated, AmerisourceBergen maintains compliance processes and quality systems to meet federal, state, and international requirements. This includes controlled substance handling protocols, temperature-sensitive product controls, serialization and traceability to meet regulatory mandates, and dedicated processes for return and recall management. Scale and strategic role While exact operations and scale metrics evolve, AmerisourceBergen is consistently described in public corporate materials as one of the leading global pharmaceutical sourcing and distribution services companies. The company’s strategic role is to streamline supply chains, enable manufacturer commercialization efforts, and provide clinical and logistical services that support access to medicines across the healthcare system. Through its distribution network and manufacturer services, AmerisourceBergen plays a central role in connecting drug makers with the point-of-care and in supporting the administrative and clinical processes that accompany modern pharmaceutical therapies.